# Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/abiraterone-acetate-plus-prednisone-in-patients-with-newly-diagnosed-high-risk/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Karim Fizazi,NamPhuong Tran,Luis Fein,Nobuaki Matsubara,A. Rodrı́guez-Antolı́n,B. Yа. Alekseev,Mustafa Özgüroğlu,Dingwei Ye,Susan Feyerabend,Andrew Protheroe,Giri Sulur,Yesenia Luna,Susan Li,Suneel Mundle,Kim N. |
| Citations | 827 |
| DOI | 10.1016/s1470-2045(19)30082-8 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.thelancet.com/article/S1470204519300828/pdf |
| OpenAlex ID | https://openalex.org/W2938589827 |
| PMID | 30987939 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Suneel Mundle](https://scholariq.org/researchers/suneel-mundle/)
- [Kim N.](https://scholariq.org/researchers/kim-n/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.